哮喘联盟

   摘要
   目的：为了评估感冒和咳嗽药物和这些药物在初级卫生保健所中对儿童的合理性，对阿斯图里亚斯卫生服务区域V的儿童进行评估。
   材料和方法：采用横断面的、描述性、回顾性研究，对呼吸系统疾病和2011年在阿斯图里亚斯卫生服务区域V工作的6名初级卫生保健儿科医生的处方进行分析。对这些药物的适用性进行评估。对药物数据表和临床建议（临床指南，协议或报告）进行分析。
   结果：对424种感冒和咳嗽药进行分析，包括249种镇咳药，155种化痰药，和20种“其他”药物。儿童平均年龄为5岁。总计有85.1％不合理处方。11.6％超适应症用药。在不合理的处方中有82.8％呼吸道感染（R74）相关处方，73％咳嗽、咳痰、发烧（R05）相关处方。所有6岁以下儿童的处方药均不合理。99.4％化痰药/“其他”药物应用不合理，75.1％镇咳药也存在不合理用药现象。
   结论：儿童中感冒、咳嗽药处方率高，其中有85％的用药存在不合理现象。儿童应该只接受具有良好的风险收益比的药物。儿科医师应更了解儿科的相关药物知识，并将这些药物知识告知家长，其他医生和护士。
 

（苏欣 审校）
An Pediatr (Barc). 2015 Apr 4. pii: S1695-4033(15)00097-1. doi: 10.1016/j.anpedi.2015.02.022. [Epub ahead of print]
 

Use of cold and cough medications prescribed in Primary Care clinics for children less than 14 years.
 

[Article in Spanish]
Suárez-Castañón C1, Modroño-Riaño G2, López-Vilar P3, Martínez-Blanco J4, Iglesias-Cabo T5, Solís-Sánchez G6.
Author information
 

Abstract
OBJECTIVE:To evaluate cold and cough medications and their suitability in children in Primary Health Care in Area V of the Asturian Health Service.
MATERIAL AND METHODS:A cross-sectional, descriptive and retrospective study was conducted in which an analysis was performed of the respiratory diseases and the prescriptions of 6 Primary Health Care paediatricians who worked in Area V of the Asturian Health Service in 2011. An evaluation was made on the suitability of these medications. An analysis was also made of the drug datasheet and clinical recommendations (clinical guidelines, protocols or reports).
RESULTS:A total of 424 cold and cough drugs: 249 antitussives, 155 mucolytics, and 20 "others" were analyzed. The mean age was 5 years old. There was a total of 85.1% unsuitable prescriptions. Off-label drugs were used in 11.6%. The prescribing was considered unsuitable in 82.8% of prescriptions associated with R74, and 73% of R05. All of the prescription drugs in children under 6 years old were unsuitable. Mucolytics/"others" were not suitable in 99.4%, nor antitussives in 75.1%.
CONCLUSIONS:There is a high level of cold and cough drugs being prescribed in children, with 85% of these being unsuitable. Children should only receive drugs with a good risk and benefit ratio. Pediatricians should try to improve the information about pediatric drug use and spread this information to parents, doctors and nurses.
 

An Pediatr (Barc). 2015 Apr 4. pii: S1695-4033(15)00097-1. doi: 10.1016/j.anpedi.2015.02.022. [Epub ahead of print]